Essity B 297.2 (+0.7 SEK) on 28-May-2023 17:29
Select region

Global Site

USA USA Russia Russia Germany Germany Mexico Mexico Netherlands Netherlands France France Sweden Sweden Italy Italy Spain Spain

Did you mean

    Advanced search

    Quick results

    View all results

    These might help

    Corporate press releases

    Corporate News

    Investor Relations Calendar

    Essity logo
    Brands

    Company

    Company

    Essity at a Glance
    Purpose and Vision Our Beliefs Our History The Essity Brand
    Business Areas
    Health & Medical Consumer Goods Professional Hygiene Market and Trends E-Commerce
    Breaking Barriers to Well-being
    Stories and Videos Partnerships Insights Events
    Strategy
    Our Strategic Priorities

    Brands

    Brands

    Sustainability

    Sustainability

    What We Do
    Well-being More from Less Circularity and After-use
    How We Do It
    Responsible Sourcing Resource-efficient Production Responsible Business
    Why We Do It
    Sustainable Development Goals Science Based Targets

    Innovation

    Innovation

    Products and Solutions
    Digitalization
    Essity Ventures
    Awards

    Careers

    Careers

    Job Opportunities
    Work at Essity
    Commitment to Our Employees Learning and Development Why Choose Essity? Barrier Breakers
    Students and Graduates
    Graduates Students Internships Apprenticeships
    Career Stories
    Alumni Network
    Connect with Us
    Total Rewards

    Media

    Media

    Global News features
    Global Press releases
    US News
    Images & Video
    Essity in social media
    Home
    Media
    Global Press releases
    2023
    Media
    Global News features Global Press releases US News Images & Video Essity in social media

    April 26, 2023

    Essity initiates a strategic review of its ownership of Vinda and the Consumer Tissue Private Label Europe business

    The hygiene and health company Essity has decided to initiate a strategic review of the company’s ownership of the Asian hygiene company Vinda International Holdings Ltd (Vinda) and the Consumer Tissue Private Label Europe business with the aim of reducing Consumer Tissue’s share of the company’s total sales.

    Essity continuously evaluates the product portfolios within the company’s three business areas, Health & Medical, Consumer Goods and Professional Hygiene, to achieve increased long-term value creation. In line with this, Essity is initiating a strategic review of the company’s ownership of Vinda and the Consumer Tissue Private Label Europe business. The strategic review includes exploring different options and may result in divestments, although no such decisions have yet been taken.

    Essity’s net sales for 2022 amounted to approximately SEK 156bn, of which Vinda accounted for approximately 16% and the Consumer Tissue Private Label Europe business approximately 6%. Vinda and the Consumer Tissue Private Label Europe business accounted for approximately 34% of the business area Consumer Goods net sales 2022 and approximately 45% of the Consumer Tissue category net sales in 2022.

    Essity’s ownership in Vinda amounts to 51.59% and Essity consolidates 100%. Vinda is listed on the Hong Kong Stock Exchange and had a market capitalization of approximately HKD 26bn (approximately SEK 34bn) at the end of trading on April 25, 2023. Vinda’s net sales in 2022 amounted to approximately SEK 25.1bn and EBITA amounted to approximately SEK 1.1bn. Of Vinda’s net sales, 83% were related to tissue and 17% were related to personal care.

    Net sales for the Consumer Tissue Private Label Europe business amounted to approximately SEK 9.8bn in 2022, corresponding to about 15% of net sales in the Consumer Tissue category. The business encompasses seven production facilities in Belgium, France, Germany and Italy with approximately 1,900 employees. Other operations in Consumer Tissue, which include own brands and strategic collaborations to develop retailer brands, are a prioritized business focusing on innovation, brands and sustainability.

    NB: This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 14:45 CET on April 26, 2023. 

    Karl Stoltz, Media Relations Director, +46 709 426 338

    Essity Press release
    Back to press releases

    Share this

    Essity logo
    Brands Company Essentials Initiative Contact us Do not sell or share my personal data
    Privacy Policy Supplemental State Privacy Policy Cookies Terms and conditions

    Tel 1 610 499 3700

    © Essity | 2929 Arch Street, Suite 2600, Philadelphia, Pennsylvania 19104